Literature DB >> 6975328

Vasoactive intestinal polypeptide modulation of lymphocyte adenylate cyclase.

M S O'Dorisio, N S Hermina, T M O'Dorisio, S P Balcerzak.   

Abstract

Vasoactive intestinal polypeptide (VIP) was found to be a potent stimulator of lymphocyte adenylate cyclase activity. VIP-induced activation of adenylate cyclase was specific for lymphocytes among peripheral blood cells; i.e., VIP did not stimulate the adenylate cyclase activity of neutrophils, monocytes, or platelets. The VIP-induced activation of lymphocyte adenylate cyclase was time, temperature, and concentration dependent. VIP and the GTP analog, Gpp(NH)p, acted synergistically to stimulate lymphocyte adenylate cyclase; stimulation by VIP and PGE1 was additive; and VIP activation was antagonized by somatostatin. VIP-mediated activation of lymphocyte adenylate cyclase was observed in normal human T cells, B cells obtained from a patient with chronic lymphocytic leukemia, and a human T cell culture line. The Raji human B cell culture line did possess adenylate cyclase activity, but this activity was not stimulated by VIP. These results suggest that lymphocytes possess functional receptors for VIP and that this peptide may play a role in modulation of lymphocyte function.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6975328

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Vasoactive intestinal peptide stimulates immunoglobulin production and growth of human B cells.

Authors:  C Ishioka; A Yoshida; H Kimata; H Mikawa
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

Review 2.  Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions.

Authors:  Mario Delgado; Doina Ganea
Journal:  Amino Acids       Date:  2011-12-03       Impact factor: 3.520

3.  Somatostatin receptors on human lymphocytes and leukaemia cells.

Authors:  K Hiruma; T Koike; H Nakamura; T Sumida; T Maeda; H Tomioka; S Yoshida; T Fujita
Journal:  Immunology       Date:  1990-12       Impact factor: 7.397

4.  Selective effects of vasoactive intestinal peptide on the mitogenic response of murine T cells.

Authors:  C A Ottaway
Journal:  Immunology       Date:  1987-10       Impact factor: 7.397

Review 5.  Immunomodulating peptides.

Authors:  G H Werner; F Floc'h; D Migliore-Samour; P Jollès
Journal:  Experientia       Date:  1986-05-15

6.  Identification of lymphoid cell lines bearing receptors for somatostatin.

Authors:  H Nakamura; T Koike; K Hiruma; T Sato; H Tomioka; S Yoshida
Journal:  Immunology       Date:  1987-12       Impact factor: 7.397

7.  Priming effect of vasoactive intestinal peptide on the respiratory burst of neutrophils non-mediated by plasma membrane receptors.

Authors:  M A López-González; M Lucas
Journal:  Experientia       Date:  1994-05-15

8.  Human intraepithelial lymphocytes. Immunomodulation and receptor binding of vasoactive intestinal peptide.

Authors:  A I Roberts; A Panja; R E Brolin; E C Ebert
Journal:  Dig Dis Sci       Date:  1991-03       Impact factor: 3.199

9.  Functional and immunological responses of Jurkat lymphocytes transfected with the substance P receptor.

Authors:  J Sudduth-Klinger; M Schumann; P Gardner; D G Payan
Journal:  Cell Mol Neurobiol       Date:  1992-10       Impact factor: 5.046

Review 10.  Neuroendocrine modulation of the immune system. Possible implications for inflammatory bowel disease.

Authors:  F Shanahan; P Anton
Journal:  Dig Dis Sci       Date:  1988-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.